Media/method | ED I | ED II | ED III | Follow- up | Definite diagnosis | |
---|---|---|---|---|---|---|
Exhaled breath | Nitric Oxide | ● | ● | ● | ● | ● |
Volatile organic compounds | ● | ● | ● | ● | ● | |
Exhaled breath condensate | Cytokines (IL1a,-2,-4,-5,-6,-10,- 12p70,-13,-18, IFNg, TNFa) | ● | ● | ● | ● | ● |
Chemokines (MIP1a, MIF, eotaxin, RANTES, IL8, MCP1) | ● | ● | ● | ● | ● | |
Adhesion molecules (sICAM) | ● | ● | ● | ● | ● | |
Nitrate/nitrite | ● | ● | ● | ● | ● | |
Blood | White blood cell count, differentiation, number of eosinophils | ● | ||||
Total Immunoglobulin E (IgE), and specific IgE | ● | ● | ||||
Regulatory T cells | ● | |||||
Gene polymorphism (e.g. in IL-4, IL-13, TNF-alpha, ADAM33) | ● | |||||
Gene expression (e.g. in IL-4, IL-13, TNF-alpha) | ● | |||||
Anti bodies against Mycoplasma en Chlamydia pneumoniae | ● | |||||
Saliva | Colonisation of Pneumococcen, Haemophilus (para)influenza, Staphylococcus aureus | ● | ● | |||
Faeces | Colonisation of E.Coli en Clostridium difficile | ● | ||||
Lung function test | Airway resistance (MicroRint) before and after bronchodilator | ● | ● | ● | ● | |
Dynamic spirometry (MEFV, FEV1, FVC, MEF50) before and after bronchodilator | ● | |||||
Histamine provocation test | ● | |||||
Questionnaire | Parental administrated respiratory symptoms (ISAAC) | ● | ● | ● | ● | ● |
Demographic factors (e.g. smoking, pets) | ● | ● | ● | ● | ● | |
Parental administrated Quality of life (FSII) | ● | ● | ● | ● | ● |